Etanercept (genetical recombination) ( DrugBank: Etanercept )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 107 | Juvenile idiopathic arthritis | 1 |
107. Juvenile idiopathic arthritis
Clinical trials : 447 / Drugs : 297 - (DrugBank : 57) / Drug target genes : 52 - Drug target pathways : 146
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01145352 (ClinicalTrials.gov) | July 2009 | 9/6/2010 | Enbrel-Juvenile Idiopathic Arthritis (JIA) Use Results Survey [All-Case Surveillance] | Enbrel-JIA Use Results Survey [All-Case Surveillance] | Juvenile Idiopathic Arthritis | Drug: Etanercept (genetical recombination) | Pfizer | NULL | Completed | 5 Years | 16 Years | All | 113 | N/A | Japan |